[Effectiveness and tolerability of zoledronic acid in the treatment of metastatic prostate cancer].
Cózar Olmo JM, Carballido Rodriguez J, Luque Galvez P, Tabernero Gómez AG, Barreiro Mouro A, Sánchez Sánchez E, González Enguita C, Alcover García J, Garcia-Galisteo E, Abascal García JM, Sanchez Chapado M, GómezVeiga F, Minguez Martínez RJ, Rodriguez Antolin A, Medina López RA, Rico Morales M, Regadera Sejas FJ, Búcar Terrades S, Jamardo Gonzalez D, Gálvez R.
Cózar Olmo JM, et al.
Actas Urol Esp. 2008 May;32(5):492-501. doi: 10.1016/s0210-4806(08)73873-7.
Actas Urol Esp. 2008.
PMID: 18604999
Clinical Trial.
Spanish.